Daniel Clark
Stock Analyst at Leerink Partners
(3.34)
# 2,387
Out of 5,074 analysts
52
Total ratings
60%
Success rate
9.4%
Average return
Main Sectors:
Stocks Rated by Daniel Clark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SLDB Solid Biosciences | Reiterated: Buy | $20 | $6.19 | +223.10% | 1 | Oct 20, 2026 | |
| PCRX Pacira BioSciences | Reiterated: Hold | $28 → $37 | $36.34 | +0.44% | 2 | Oct 9, 2026 | |
| ELAN Elanco Animal Health | Reiterated: Buy | $30 → $34 | $22.69 | +49.85% | 15 | Oct 1, 2026 | |
| ZTS Zoetis | Reiterated: Hold | n/a | $82.00 | - | 13 | Oct 1, 2026 | |
| AMRX Amneal Pharmaceuticals | Reiterated: Buy | $23 | $20.48 | +12.30% | 2 | Sep 17, 2026 | |
| ANIP ANI Pharmaceuticals | Initiated Coverage: Buy | $104 | $73.75 | +41.02% | 1 | Sep 9, 2026 | |
| BLCO Bausch + Lomb | Initiated Coverage: Buy | $24 | $17.43 | +37.69% | 1 | Sep 9, 2026 | |
| COLL Collegium Pharmaceutical | Initiated Coverage: Buy | $45 | $23.50 | +91.49% | 1 | Sep 9, 2026 | |
| HROW Harrow | Initiated Coverage: Buy | $45 | $28.15 | +59.86% | 1 | Sep 9, 2026 | |
| PHAT Phathom Pharmaceuticals | Initiated Coverage: Hold | $10 | $7.01 | +42.65% | 1 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $18.48 | +8.23% | 1 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $745 → $785 | $566.76 | +38.51% | 13 | Nov 3, 2025 |
Solid Biosciences
Oct 20, 2026
Reiterated: Buy
Price Target: $20
Current: $6.19
Upside: +223.10%
Pacira BioSciences
Oct 9, 2026
Reiterated: Hold
Price Target: $28 → $37
Current: $36.34
Upside: +0.44%
Elanco Animal Health
Oct 1, 2026
Reiterated: Buy
Price Target: $30 → $34
Current: $22.69
Upside: +49.85%
Zoetis
Oct 1, 2026
Reiterated: Hold
Price Target: n/a
Current: $82.00
Upside: -
Amneal Pharmaceuticals
Sep 17, 2026
Reiterated: Buy
Price Target: $23
Current: $20.48
Upside: +12.30%
ANI Pharmaceuticals
Sep 9, 2026
Initiated Coverage: Buy
Price Target: $104
Current: $73.75
Upside: +41.02%
Bausch + Lomb
Sep 9, 2026
Initiated Coverage: Buy
Price Target: $24
Current: $17.43
Upside: +37.69%
Collegium Pharmaceutical
Sep 9, 2026
Initiated Coverage: Buy
Price Target: $45
Current: $23.50
Upside: +91.49%
Harrow
Sep 9, 2026
Initiated Coverage: Buy
Price Target: $45
Current: $28.15
Upside: +59.86%
Phathom Pharmaceuticals
Sep 9, 2026
Initiated Coverage: Hold
Price Target: $10
Current: $7.01
Upside: +42.65%
Sep 9, 2026
Initiated Coverage: Buy
Price Target: $20
Current: $18.48
Upside: +8.23%
Nov 3, 2025
Reiterated: Buy
Price Target: $745 → $785
Current: $566.76
Upside: +38.51%